Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429561 (US10550089, Example 35 | US10995072, Example 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429560 (US10550089, Example 34 | US10995072, Example 35) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429568 (US10550089, Example 42 | US10995072, Example 42) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429576 (US10550089, Example 50 | US10995072, Example 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429566 (US10550089, Example 40 | US10995072, Example 63) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 860 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429544 (US10550089, Example 18 | US10995072, Example 18) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429585 (US10550089, Example 59 | US10995072, Example 59) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 900 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429542 (US10550089, Example 16) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429563 (US10550089, Example 37 | US10995072, Example 37) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 970 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429577 (US10550089, Example 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 970 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429543 (US10550089, Example 17 | US10995072, Example 17) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.05E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429588 (US10550089, Example 62 | US10995072, Example 62) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429516 (US10550089, Example 3 | US10995072, Example 2) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.29E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429580 (US10550089, Example 54 | US10995072, Example 56) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429579 (US10550089, Example 53) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.45E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429576 (US10550089, Example 50 | US10995072, Example 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429540 (US10550089, Example 14 | US10995072, Example 64) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.52E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429561 (US10550089, Example 35 | US10995072, Example 36) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.61E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429578 (US10550089, Example 52 | US10995072, Example 52) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.63E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429582 (US10550089, Example 56) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.65E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429536 (US10550089, Example 10 | US10995072, Example 11) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.66E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429586 (US10550089, Example 60 | US10995072, Example 60) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429560 (US10550089, Example 34 | US10995072, Example 35) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429564 (US10550089, Example 38 | US10995072, Example 38) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429573 (US10550089, Example 47 | US10995072, Example 47) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.12E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429572 (US10550089, Example 46 | US10995072, Example 46) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.17E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429567 (US10550089, Example 41 | US10995072, Example 41) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.19E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429580 (US10550089, Example 54 | US10995072, Example 56) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.64E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429455 (US10550089, Example 1 | US10995072, Example 1) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.93E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429568 (US10550089, Example 42 | US10995072, Example 42) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429586 (US10550089, Example 60 | US10995072, Example 60) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429563 (US10550089, Example 37 | US10995072, Example 37) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429577 (US10550089, Example 51) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429587 (US10550089, Example 61) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.38E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429559 (US10550089, Example 33 | US10995072, Example 33) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429552 ((4-Fluoro-2-((S)-3- fluoropyrrolidin-1- yl)phenyl)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.87E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429516 (US10550089, Example 3 | US10995072, Example 2) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.92E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429538 (US10550089, Example 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429589 (US10550089, Example 63) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.06E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429544 (US10550089, Example 18 | US10995072, Example 18) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429557 (US10550089, Example 31 | US10995072, Example 31) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.32E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429546 (US10550089, Example 20 | US10995072, Example 20) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429548 (US10550089, Example 22 | US10995072, Example 22) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429556 ((2-(3- Azabicyclo[3.1.0] hexan-3-yl)-4- fluorophen...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.67E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429566 (US10550089, Example 40 | US10995072, Example 63) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429538 (US10550089, Example 12) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429573 (US10550089, Example 47 | US10995072, Example 47) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.91E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 124 total ) | Next | Last >> |